Compugen Ltd. To Present Cancer Immunotherapy Programs At Three International Cancer Conferences In March
Published: Feb 20, 2014
Compugen Ltd. (NASDAQ: CGEN) today announced that its scientists are presenting at three international cancer conferences next month:
Cancer Progress, March 4-5, 2014 in New York, NY
Galit Rotman, PhD, Chief Scientist of Therapeutics, Compugen: Taking Immunotherapy Seriously: New Targets and Combinations
Help employers find you! Check out all the jobs and post your resume.